Lung transplantation for patients with severe COVID-19-Reference-Cited by-同舟云学术

Lung transplantation for patients with severe COVID-19

Published:2020-12-16 Issue:574 Volume:12 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Bharat Ankit¹^ORCID,Querrey Melissa¹^ORCID,Markov Nikolay S.²^ORCID,Kim Samuel¹^ORCID,Kurihara Chitaru¹,Garza-Castillon Rafael¹^ORCID,Manerikar Adwaiy¹^ORCID,Shilatifard Ali³^ORCID,Tomic Rade²,Politanska Yuliya²^ORCID,Abdala-Valencia Hiam²^ORCID,Yeldandi Anjana V.⁴,Lomasney Jon W.⁴^ORCID,Misharin Alexander V.²^ORCID,Budinger G. R. Scott²^ORCID

Affiliation:

1. Division of Thoracic Surgery, Northwestern Memorial Hospital, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

2. Division of Pulmonary and Critical Care Medicine, Northwestern Memorial Hospital, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

3. Department of Biochemistry and Molecular Genetics, Northwestern Memorial Hospital, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

4. Department of Pathology, Northwestern Memorial Hospital, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

Abstract

Some patients with severe COVID-19 develop end-stage pulmonary fibrosis for which lung transplantation may be the only treatment.

Funder

National Institute on Aging

National Heart, Lung, and Blood Institute

National Institute of Allergy and Infectious Diseases

U.S. Department of Veterans Affairs

Northwestern University

Chan Zuckerberg Initiative

Publisher

American Association for the Advancement of Science (AAAS)